Chay’s Neurotech Newsletter

No Code, No Market

Clinical Data and Regulatory Approval is often enough to raise a decent round. But ROI comes from Market Access.

Chay’s Neurotech Newsletter's avatar
Chay’s Neurotech Newsletter
May 26, 2026
∙ Paid

Another preface for you. I wrote this as I am doing more and more research around market access due to a growing demand from my clients in the start up world.

I was speaking to the founder of a European neurotech company recently. They have been building and raising for a couple of years, the product is tried and tested in Europe and I was asking about t…

User's avatar

Continue reading this post for free, courtesy of Chay’s Neurotech Newsletter.

Or purchase a paid subscription.
© 2026 The Neurotech Newsletter · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture